Introduction
Didesmethyl Sibutramine is a primary active metabolite of sibutramine, an appetite-suppressing agent formerly used for the treatment of obesity. It is formed in vivo through sequential N-demethylation of sibutramine by hepatic cytochrome P450 enzymes, primarily CYP3A4 and CYP2B6. Didesmethyl sibutramine retains pharmacological activity by inhibiting the reuptake of norepinephrine, serotonin, and dopamine, contributing to appetite suppression and energy balance modulation. Due to its well-defined chemical structure, metabolic significance, and bioactivity, didesmethyl sibutramine serves as an important reference compound in pharmacokinetic studies, metabolic profiling, and drug monitoring research.
COA
Publication 
Loading ......
